Abstract
Background: Annular lichenoid dermatitis of youth (ALDY) is an uncommon disease clinically reminiscent of morphea, annular erythema or mycosis fungoides. Objective: To describe the histological and clinical features of a small series of patients with ALDY and to review the literature. Patients: We describe the clinical and histological features of six patients (age range 7-79 years) with asymptomatic erythematous macules and patches with a red-brownish border and central hypopigmentation, mostly distributed on the groin and flanks. Histologically, all cases showed lichenoid dermatitis limited to the tips of rete ridges, with many intraepidermal CD8+ and some CD4+ T cells. T cell receptor rearrangement was absent in all cases. A total of 44 patients with a consistent clinical and histological picture have been described. The disease is sensitive to topical and/or systemic corticosteroids. Conclusions: ALDY is a unique lichenoid dermatitis for whose diagnosis a clinical-pathological correlation is essential. The disease typically affects young patients, more rarely adults and elderly.
Journal Section:
Editor's choice
References
1.
Annessi G, Paradisi M, Angelo C, et al: Annular lichenoid dermatitis of youth. J Am Acad Dermatol 2003;49:1029-1036.
[PubMed]
2.
De la Torre C, Florez A, Fernandez-Redondo V: Negative results of patch testing with standard and textile series in a case of annular lichenoid dermatitis of youth. J Am Acad Dermatol 2005;53:172-173.
[PubMed]
3.
Durdu M, Akyilmaz M, Tuncer L: Annular lichenoid dermatosis of youth. Pediatr Dermatol 2007;24:582-584.
[PubMed]
4.
Kim H, Kim MB, Ko HC, et al: A case of annular lichenoid dermatitis of youth (abstract). Kor J Dermatol 2007;45:173.
5.
Kleikamp S, Kutzner H, Frosch PJ: Annular lichenoid dermatitis of youth - a further case in a 12-year-old girl. J Dtsch Dermatol Ges 2008;6:653-656.
[PubMed]
6.
Sans V, Leaute-Labreze C, Vergier B, Taieb A: A further case of annular lichenoid dermatitis of youth: role of the anti-hepatitis B immunization? Pediatr Dermatol 2008;25:577-579.
[PubMed]
7.
Cesinaro AM, Sighinolfi R, Greco A, et al: Annular lichenoid dermatitis of youth … and beyond: a series of 6 cases. Am J Dermatopathol 2009;31:263-267.
[PubMed]
8.
Tsoitis G, Kanitakis J, Kyamidis K, et al: Annular lichenoid dermatosis of youth. J Eur Acad Dermatol Venereol 2009;23:1339-1340.
[PubMed]
9.
Durdu M, Baba M, Adigüzel A, Bal N: A young case with annular lichenoid dermatitis (in Turkish). Turkderm 2009;43:32-34.
10.
Huh W, Kanitakis J: Annular lichenoid dermatosis of youth: report of the first Japanese case and published work review. J Dermatol 2010;37:531-533.
[PubMed]
11.
Leger MC, Gonzalez ME, Meehan S, Schaffer JV: Annular lichenoid dermatitis of youth in an American boy. J Am Acad Dermatol 2013;68:e155-e156.
[PubMed]
12.
Van Dongen JJM, Langerak AW, Brüggemann M, et al: Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-2317.
[PubMed]
13.
Beaufils N, Ben Lassoued A, Essaydi A: Analysis of T-cell receptor-γ gene rearrangements using heteroduplex analysis by high-resolution microcapillary electrophoresis. Leuk Res 2012;36:1119-1123.
[PubMed]
14.
Fleischmajer R, Nedwich A: Generalised morphea. I. Histology of the dermis and subcutaneous tissue. Arch Dermatol 1972;106:509-514.
[PubMed]
15.
Stone ML, Styles AR, Cockerell CJ, Pandya AG: Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature. Cutis 2001;67:133-138.
[PubMed]
16.
Ardigo M, Borroni G, Muscardin L, et al: Hypopigmented mycosis fungoides in Caucasian patients: a clinicopathologic study of 7 cases. J Am Acad Dermatol 2003;49:264-270.
[PubMed]
17.
Khopkar U, Doshi BR, Dongre AM, Gujral S: A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides. Indian J Dermatol Venereol Leprol 2011;77:167-173.
[PubMed]
18.
Uhlenhake EE, Mehregan DM: Annular hypopigmented mycosis fungoides: a novel ringed variant. J Cutan Pathol 2012;39:535-539.
[PubMed]
19.
Breathnach SM, McKee PH, Smith NP: Hypopigmented mycosis fungoides: report of five cases with ultrastructural observation. Br J Dermatol 1982;106:643-649.
[PubMed]
20.
Castano E, Glick S, Wolgast L, et al: Hypopigmented mycosis fungoides in childhood and adolescence: a long-term retrospective study. J Cutan Pathol 2013;40:924-934.
[PubMed]
21.
El-Shabrawi-Caelen L, Cerroni L, Medeiros LJ, McCalmont TH: Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype. Am J Surg Pathol 2002;26:450-457.
[PubMed]
22.
Magro CM, Hagen JW, Crowson AN, et al: Hypopigmented interface T-cell dyscrasia: a form of cutaneous T-cell dyscrasia distinct from hypopigmented mycosis fungoides. J Dermatol 2014;41:609-617.
[PubMed]
23.
Nasu K, Said J, Vonderheid E, et al: Immunopathology of cutaneous T-cell lymphomas. Am J Pathol 1985;119:436-447.
[PubMed]
24.
Whittam LR, Calonje E, Orchard G, et al: CD8-positive juvenile onset mycosis fungoides: an immunohistochemical and genotypic analysis of six cases. Br J Dermatol 2000;143:1199-1204.
[PubMed]
25.
Lage D, Juliano PB, Metze K, et al: Lichen planus and lichenoid drug-induced eruption: a histological and immunohistochemical study. Int J Dermatol 2012;51:1199-1205.
[PubMed]
© 2015 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2015
You do not currently have access to this content.
